RSCM

Rock Springs Capital Management Portfolio holdings

AUM $1.6B
This Quarter Return
+40.44%
1 Year Return
+25.98%
3 Year Return
+194.74%
5 Year Return
+336.76%
10 Year Return
+2,199.29%
AUM
$3.16B
AUM Growth
+$3.16B
Cap. Flow
+$71.7M
Cap. Flow %
2.27%
Top 10 Hldgs %
29.57%
Holding
150
New
12
Increased
35
Reduced
32
Closed
19

Top Buys

1
JNJ icon
Johnson & Johnson
JNJ
$73.2M
2
HUM icon
Humana
HUM
$67.8M
3
APRE icon
Aprea Therapeutics
APRE
$33.2M
4
AXNX
Axonics, Inc. Common Stock
AXNX
$24.9M
5
ACAD icon
Acadia Pharmaceuticals
ACAD
$20.7M

Top Sells

1
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
$49M
2
MDCO
Medicines Co
MDCO
$41.8M
3
ABBV icon
AbbVie
ABBV
$39.8M
4
SYK icon
Stryker
SYK
$38.7M
5
CI icon
Cigna
CI
$29M

Sector Composition

1 Healthcare 90.33%
2 Consumer Staples 0.66%
3 Consumer Discretionary 0.48%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ODT
76
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$14M 0.44%
430,000
– –
KRTX
77
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$13.6M 0.43%
180,000
-180,400
-50% -$13.6M
FGEN icon
78
FibroGen
FGEN
$47.8M
$13.1M 0.41%
306,000
– –
ZGNX
79
DELISTED
Zogenix, Inc.
ZGNX
$13M 0.41%
250,000
– –
RIGL icon
80
Rigel Pharmaceuticals
RIGL
$697M
$11.8M 0.37%
5,497,900
+1,297,900
+31% +$2.78M
MYOK
81
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$11.7M 0.37%
+160,000
New +$11.7M
CNST
82
DELISTED
Constellation Pharmaceuticals, Inc.
CNST
$11M 0.35%
+233,500
New +$11M
BHVN
83
DELISTED
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
$10.9M 0.34%
200,000
-143,500
-42% -$7.81M
ARVN icon
84
Arvinas
ARVN
$568M
$10.3M 0.32%
250,000
+100,000
+67% +$4.11M
DERM
85
DELISTED
Dermira, Inc.
DERM
$9.85M 0.31%
650,000
-125,000
-16% -$1.9M
FOLD icon
86
Amicus Therapeutics
FOLD
$2.43B
$9.74M 0.31%
1,000,000
– –
BMY icon
87
Bristol-Myers Squibb
BMY
$96.5B
$9.63M 0.3%
+150,000
New +$9.63M
DVAX icon
88
Dynavax Technologies
DVAX
$1.19B
$9.01M 0.28%
1,575,000
-275,000
-15% -$1.57M
QTTB icon
89
Q32 Bio
QTTB
$20.9M
$8.8M 0.28%
425,000
– –
TVTX icon
90
Travere Therapeutics
TVTX
$1.56B
$8.17M 0.26%
575,000
-375,000
-39% -$5.33M
RYTM icon
91
Rhythm Pharmaceuticals
RYTM
$6.85B
$7.92M 0.25%
345,000
+40,000
+13% +$918K
MNTA
92
DELISTED
Momenta Pharmaceuticals, Inc.
MNTA
$7.89M 0.25%
400,000
– –
MYOV
93
DELISTED
Myovant Sciences Ltd.
MYOV
$7.76M 0.25%
500,000
+50,000
+11% +$776K
TBIO
94
DELISTED
Translate Bio, Inc. Common Stock
TBIO
$7.73M 0.24%
950,000
-75,000
-7% -$611K
MRSN icon
95
Mersana Therapeutics
MRSN
$36.5M
$7.07M 0.22%
1,233,000
-167,000
-12% -$957K
PHAS
96
DELISTED
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
$6.87M 0.22%
1,125,000
-291,900
-21% -$1.78M
ICPT
97
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$6.74M 0.21%
54,400
– –
GRTX
98
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
$6.58M 0.21%
+500,000
New +$6.58M
CGEN icon
99
Compugen
CGEN
$134M
$6.56M 0.21%
1,100,000
– –
NGM
100
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
$6.49M 0.21%
351,100
– –
2 3
4
5 6